These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9526811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
    Schonfeld G, Aguilar-Salina C, Elias N.
    Am J Cardiol; 1998 Feb 26; 81(4A):43B-46B. PubMed ID: 9526813
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.
    Endocrinology; 1999 Nov 26; 140(11):5293-302. PubMed ID: 10537160
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Statins: effective antiatherosclerotic therapy.
    Blumenthal RS.
    Am Heart J; 2000 Apr 26; 139(4):577-83. PubMed ID: 10740137
    [Abstract] [Full Text] [Related]

  • 8. Aggressive lipid therapy in the statin era.
    Farmer JA.
    Prog Cardiovasc Dis; 1998 Apr 26; 41(2):71-94. PubMed ID: 9790411
    [Abstract] [Full Text] [Related]

  • 9. The evolving role of statins in the management of atherosclerosis.
    Vaughan CJ, Gotto AM, Basson CT.
    J Am Coll Cardiol; 2000 Jan 26; 35(1):1-10. PubMed ID: 10636252
    [Abstract] [Full Text] [Related]

  • 10. Comparison of statins in hypertriglyceridemia.
    Stein EA, Lane M, Laskarzewski P.
    Am J Cardiol; 1998 Feb 26; 81(4A):66B-69B. PubMed ID: 9526817
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ, Watson KE, Talbert RL.
    J Manag Care Pharm; 2008 Oct 26; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.
    Vega GL, Grundy SM.
    Am J Cardiol; 1998 Feb 26; 81(4A):36B-42B. PubMed ID: 9526812
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
    Davignon J, Hanefeld M, Nakaya N, Hunninghake DB, Insull W, Ose L.
    Am J Cardiol; 1998 Aug 27; 82(4B):32J-39J. PubMed ID: 9737644
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 27; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 19. [New possibilities of correction of hypercholesterolemia in patients with diabetes mellitus].
    Pan'kiv VI.
    Lik Sprava; 2014 Nov 27; (5-6):56-67. PubMed ID: 25906648
    [Abstract] [Full Text] [Related]

  • 20. Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD?
    Hochholzer W, Giugliano RP.
    Curr Atheroscler Rep; 2013 Jan 27; 15(1):290. PubMed ID: 23242605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.